Change in CEO/CFO Attendance vs. Targeted Investors Conversion Rate: United States 2019All-America Executive Team July 25, 2019 Related Articles Premium RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks Stephen Taub Biotech Surge Sends Averill to the Top of February’s Market Winners Stephen Taub Optimizing the Efficient Frontier: Opportunistic Credit Amid a Capital Structure Reset Sponsored by Davidson Kempner